Jens Gaedeke
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Cold-evoked potentials in Fabry disease and polyneuropathy.
Journal: Frontiers in pain research (Lausanne, Switzerland)
Published: December 08, 2023
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 01, 2022
Progressive Hereditary Transthyretin-Related Amyloidosis (ATTRv) Aggravated by ATTR Wild-Type and Complement Activation.
Journal: Journal of neuropathology and experimental neurology
Published: January 29, 2022
Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: December 02, 2020
NEPHRO-ZEBRA-acute troponin increase in a kidney transplant recipient-the unknown knowns?
Journal: Journal of nephrology
Published: December 02, 2020
Inosine 5'-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients.
Journal: Transplantation
Published: June 05, 2020
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP.
Journal: Blood advances
Published: April 02, 2020
The patient journey of patients with Fabry disease, Gaucher disease and Mucopolysaccharidosis type II: A German-wide telephone survey.
Journal: PloS one
Published: March 25, 2020
Bridging the Gap Between Vessels and Nerves in Fabry Disease.
Journal: Frontiers in neuroscience
Published: January 13, 2020
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS).
Journal: Clinical pharmacology and therapeutics
Published: December 09, 2019
Last Updated: 09/26/2026